Skip to main content

Day: May 6, 2021

New CentoMD® 6.0 Update Brings Deeper Insights Into Rare Diseases

CENTOGENE’s rare disease mutation database offers new features and previously unpublished variantsDatabase has grown to more than 465,000 analyzed patients, with more than 225,000 being linked to HPO terms Release includes increase of almost 19 million to over 31 million unique variants New features, including variant classification based on ACMG guidelines and streamlined HPO search tools, help to accelerate diagnosis and expand on resources for orphan drug development New biochemistry module expands on previous genetic testing foundation to further fuel the knowledge base of rare diseases HPO source code released for free use globallyCAMBRIDGE, Mass. and ROSTOCK, Germany and BERLIN, May 06, 2021 (GLOBE NEWSWIRE) — Centogene N.V. (Nasdaq: CNTG), a commercial-stage company focused on rare diseases that transforms real-world...

Continue reading

ChannelAdvisor Reports First Quarter 2021 Results; Revenue and Adjusted EBITDA Significantly Exceed Guidance

Total revenue growth accelerated to 22% year-over-year Subscription revenue growth accelerated to 17% year-over-year Revenue from brands increased 39% year-over-year RESEARCH TRIANGLE PARK, N.C., May 06, 2021 (GLOBE NEWSWIRE) — ChannelAdvisor Corporation (NYSE: ECOM), a leading provider of cloud-based e-commerce solutions that enable brands and retailers to increase global sales, today reported financial results for the quarter ended March 31, 2021. First Quarter 2021 HighlightsGAAPTotal revenue increased 22% year-over-year to $39.2 million Subscription revenue growth accelerated to 17% year-over-year Brands revenue increased 39% year-over-year GAAP net income was $5.5 million, or $0.18 per diluted share based on 31.1 million diluted weighted average shares outstanding Operating cash flow increased 46% year-over-year to $8.4...

Continue reading

TopBuild Reports First Quarter 2021 Results

Net sales increased 13.7% Gross margin expanded 30 basis points 12.9% operating margin, 13.1% on an adjusted basis, up 230 basis points Adjusted EBITDA increased 31.1%, adjusted EBITDA margin up 210 basis points $1.80 net income per diluted share, $2.02 on an adjusted basisDAYTONA BEACH, Fla., May 06, 2021 (GLOBE NEWSWIRE) —  TopBuild Corp. (NYSE:BLD), a leading installer and distributor of insulation and building material products today reported results for the first quarter ended March 31, 2021. Robert Buck, President and Chief Executive Officer, stated, “TopBuild reported another solid quarter with sales benefitting from the strong growth in both our residential and commercial businesses. Adjusted operating margins expanded at both TruTeam and Service Partners, despite the impact of severe weather in February, most notably...

Continue reading

Reata Pharmaceuticals, Inc. Announces First Quarter 2021 Financial Results and Provides an Update on Clinical Development Programs

ANNOUNCES FDA ACCEPTED FOR FILING REATA’S NDA OF BARDOXOLONE FOR THE TREATMENT OF PATIENTS WITH CKD CAUSED BY ALPORT SYNDROME IF APPROVED, BARDOXOLONE MAY BECOME THE FIRST APPROVED THERAPY FOR ALPORT SYNDROME, A LIFE-THREATENING DISEASE THAT AFFECTS 30,000 – 60,000 PATIENTS IN THE U.S. REAFFIRMS ANTICIPATED COMPLETION OF ENROLLMENT BY END OF 2021 IN PHASE 3 FALCON TRIAL FOR ADPKD FDA GRANTED TYPE C MEETING TO DISCUSS FA DEVELOPMENT PROGRAM IN 2Q 2021 CONFIRMS CASH RUNWAY THROUGH MID-2024 CONFERENCE CALL WITH MANAGEMENT ON MAY 6, 2021 AT 8:30 A.M. ET PLANO, Texas, May 06, 2021 (GLOBE NEWSWIRE) — Reata Pharmaceuticals, Inc. (Nasdaq: RETA) (“Reata,” the “Company,” “our,” “us,” or “we”), a clinical-stage biopharmaceutical company, today announced financial results for the quarter ended March 31, 2021, and provided an update on the...

Continue reading

Clear Aligners Market Size 2021 | Is Projected to Reach USD 10.04 Billion by 2028, Exhibiting a CAGR of 19.7%

Key Prominent Players Covered in the Clear Aligners Market Research Report Are Henry Schein, Inc. (Melville, U.S.) , Dentsply Sirona (York, U.S.) , Ormco Corporation (Envista) (Brea, U.S.) , 3M (Maplewood), U.S.) , Argen Corporation (San Diego, U.S.) , 3Shape A/S (Copenhagen, Denmark), Institut Straumann AG (Basel, Switzerland) , Align Technology, Inc. (San Jose, U.S.) Pune, India, May 06, 2021 (GLOBE NEWSWIRE) — The global clear aligners market size is projected to reach USD 10.04 billion by 2028, exhibiting a CAGR of 19.7% during the forecast period. In 2020, the market size stood at USD 2.41 billion, according to a report by Fortune Business Insights™, titled “Clear Aligners Market, 2021-2028”. Introduction of Advanced Teeth Aligning Solutions to Boost the Market With the demand for teeth aesthetics rapidly rising, especially...

Continue reading

Pharmaceutical Market Size 2021 | Is Projected to Reach USD 2,151.1 Billion by 2027 with Exhibiting a CAGR of 7%

Pharmaceutical Market Key Players Studied in this Report are GlaxoSmithKline plc. (London, U.K), F. Hoffmann-La Roche Ltd (Basel, Switzerland), Novartis AG (Basel, Switzerland), Johnson & Johnson Services Inc. (New Jersey, U.S), Merck & Co., Inc. (New Jersey, U.S), Pfizer (New York, U.S), AstraZeneca (Cambridge, U.K), Sanofi (Paris, France), Novo Nordisk A/S (Copenhagen, Denmark). Pune, India, May 06, 2021 (GLOBE NEWSWIRE) — According to the report, Pharmaceutical market size is projected to reach USD 2,151.1 Billion by 2027. Pharmaceutical Market was worth 5.32 billion in 2019 and will exhibit a CAGR of 7% during the forecast period. Rising focus on the healthcare industry amid the pandemic situation is anticipated to boost market growth in the near future. Healthcare industry is spending a fortune on R&D for vaccines...

Continue reading

InfuSystem Reports First Quarter 2021 Financial Results

Net Revenues: $24.5 million, a 14% increase Net Income: $0.7 million, a $1.1 million increase, Adjusted EBITDA: $6.2 million, a 51% increase, and Adjusted EBITDA margin of 25.2%, a 6.3% increase Company Reaffirms Full Year 2021 Guidance ROCHESTER HILLS, Michigan, May 06, 2021 (GLOBE NEWSWIRE) — InfuSystem Holdings, Inc. (NYSE American: INFU), (“InfuSystem” or the “Company”), a leading national health care service provider, facilitating outpatient care for durable medical equipment manufacturers and health care providers, today reported financial results for the first quarter ended March 31, 2021. 2021 First Quarter Highlights:Net revenues were $24.5 million, an increase of 14% vs. prior year. Gross profit was $14.6 million, an increase of 15% vs. prior year. Gross margin was 59.6%, an improvement of 0.8% vs. prior year. Net income...

Continue reading

ORPEA SA: Post Stabilisation Notice

PARIS, May 06, 2021 (GLOBE NEWSWIRE) — HSBC (contact: Syndicate desk, telephone: +44 207 992 8066) hereby gives notice that no stabilisation (within the meaning of the rules of the Financial Conduct Authority) was undertaken by the Stabilisation Manager(s) named below in relation to the offer of the following securities.Issuer: ORPEA SAGuarantor (if any): naAggregate nominal amount: EUR 500,000,000                  Description: 2% due 1st April 2028Offer price: 99.195Stabilising Managers: HSBC Bank plc                       This announcement is for information purposes only and does not constitute an invitation or offer to underwrite, subscribe for or otherwise acquire or dispose of any securities of the Issuer in any jurisdiction  This information is provided by RNS, the news service of the London Stock...

Continue reading

Kirkland Lake Gold Reports Solid Q1 2021 Results

TORONTO, May 06, 2021 (GLOBE NEWSWIRE) — Kirkland Lake Gold Ltd. (“Kirkland Lake Gold” or the “Company”) (TSX:KL) (NYSE:KL) (ASX:KLA) today announced the Company’s financial and operating results for the first quarter of 2021 (“Q1 2021”). The results for the quarter exceeded target levels in a number of key areas, including production and all-in sustaining costs (“AISC”) per ounce sold(1), which reflected stronger than expected production and sales at Fosterville and Detour Lake, as well as lower than planned sustaining capital expenditures. The Company’s full financial statements and management discussion & analysis are available on SEDAR at www.sedar.com and on the Company’s website at www.kl.gold. All dollar amounts are in U.S. dollars, unless otherwise noted.Q1 2021 PRODUCTION BEATS GUIDANCEProduction of 302,847 exceeded...

Continue reading

Clearway Energy, Inc. Reports First Quarter 2021 Financial Results

Raised $925 million of corporate capital through the issuance of the 2031 “Green Bond” Senior Notes Closed the acquisition of the 264 MW Mt. Storm wind project Executed a multi-year, 100 MW Resource Adequacy agreement at Marsh Landing Raising pro forma CAFD outlook Increasing the quarterly dividend by 1.5% to $0.329 per share in the second quarter of 2021; On track to achieve the upper end of 5-8% annual growth target by year endPRINCETON, N.J., May 06, 2021 (GLOBE NEWSWIRE) — Clearway Energy, Inc. (NYSE: CWEN, CWEN.A) today reported first quarter 2021 financial results, including a Net Loss of $76 million, Adjusted EBITDA of $198 million, Cash from Operating Activities of $47 million, and Cash Available for Distribution (CAFD) of $(15) million. “Clearway continues to execute on its business objectives through...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.